Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
How we work:
- PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
- COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
- BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
How you’ll make an impact:
- As a program core team member, own early commercial strategy for assigned programs.
- Develop disease and market landscapes covering patient journey, treatment paradigms, unmet needs, stakeholder decision drivers, and sources of market disruption.
- Partner with Clinical Development, Medical, Regulatory, Research, and Program Leadership to shape target product profiles and evidence-generation priorities that drive differentiation.
- Lead indication prioritization and sequencing, weighing scientific rationale, epidemiology, competitive intensity, feasibility, market access, and commercial attractiveness.
- Build market models, revenue forecasts, and risk-adjusted assessments to inform portfolio planning, investment decisions, and long-range planning.
- Design and run primary and secondary market research with physicians, payers, and patients; translate findings into decision-ready recommendations.
- Support evaluation of new targets, pipeline, lifecycle, and business development opportunities through integrated scientific and commercial assessment.
- Maintain a forward-looking view of competitors, mechanisms, clinical programs, and emerging scientific trends relevant to Kymera's portfolio.
- Identify key intelligence questions and competitive scenarios, distinguishing signal from noise and flagging implications for Kymera's programs.
- Deliver concise news-flow updates and landscape syntheses to program teams and leadership, interpreting what changed, why it matters, and what should follow.
- Attend key medical and scientific meetings to capture competitive data, synthesize in real time, and produce post-congress readouts.
- Use Kymera's AI-enabled intelligence tools to accelerate monitoring, triage, and synthesis, while maintaining rigorous source validation and traceability.
- Help improve CI processes, templates, taxonomies, and AI-supported workflows to deliver insights faster with less manual effort.
- Serve as a trusted strategic partner to program teams and functional leaders, bringing an external market and competitor lens into development decisions.
- Translate complex scientific, clinical, and financial information into crisp executive narratives and presentations.
- Frame ambiguous business questions, define the analytical approach, and drive projects to clear decisions.
- Contribute to Corporate Strategy priorities — portfolio strategy, long-range planning, investor analyses — as business needs evolve.
Skills and experience you’ll bring:
- Advanced degree in a scientific or engineering discipline strongly preferred (e.g., PhD or MS in biology, immunology, pharmacology, biomedical engineering, bioengineering, chemical engineering, or a related field).
- 6+ years of relevant experience in biopharma strategy, new product planning, commercial strategy, competitive intelligence, market research, or life-sciences consulting; exceptional candidates with a PhD and somewhat fewer post-degree years may be considered.
- Strong preference for experience at a boutique life-sciences strategy consultancy, with hands-on responsibility for new product planning, indication strategy, market opportunity assessment, competitive intelligence, forecasting, and/or portfolio strategy engagements.
- Demonstrated ability to rapidly understand complex biology, mechanisms of action, clinical trial design, endpoints, and therapeutic landscapes and connect them to strategic and commercial implications.
- Fluency in primary and secondary market research and comfort managing external vendors and expert interviews.
- Experience building or critically evaluating patient-based forecasts, epidemiology models, scenario analyses, and commercial opportunity assessments.
- Excellent written and verbal communication skills, including the ability to create concise, executive-ready PowerPoint materials and communicate effectively with scientific and senior business audiences.
- High level of proficiency with Excel and PowerPoint; strong comfort adopting AI-enabled research, synthesis, and knowledge-management tools and using them responsibly.
- Highly analytical, intellectually curious, organized, and proactive, with strong judgment and the ability to manage multiple evolving priorities in a small, fast-moving organization.
Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.
Compensation
- Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
- The anticipated base salary range for this role is $195,000 – $275,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
- Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate’s depth of experience and the capabilities they bring to the position.
Skills Required
- Advanced degree in a scientific or engineering discipline (PhD or MS preferred)
- 6+ years relevant experience in biopharma strategy, new product planning, commercial strategy, competitive intelligence, market research, or life-sciences consulting
- Experience with new product planning, indication strategy, forecasting, and portfolio strategy engagements (preferably at boutique life-sciences strategy consultancy)
- Ability to rapidly understand complex biology, MoA, clinical trial design, endpoints, and therapeutic landscapes and connect to commercial implications
- Fluency in primary and secondary market research, including managing external vendors and expert interviews
- Experience building or evaluating patient-based forecasts, epidemiology models, scenario analyses, and commercial opportunity assessments
- Excellent written and verbal communication; ability to produce executive-ready PowerPoint materials
- High proficiency with Excel and PowerPoint
- Comfort adopting and using AI-enabled research, synthesis, and knowledge-management tools responsibly
- Highly analytical, organized, proactive, with strong judgment and ability to manage multiple priorities in a fast-moving organization
Kymera Therapeutics Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Kymera Therapeutics and has not been reviewed or approved by Kymera Therapeutics.
-
Fair & Transparent Compensation — Pay is considered market‑competitive for core scientific and leadership roles, with clearly posted ranges visible for U.S. openings. Feedback suggests strong base pay aligns with comments about high salary and good pay.
-
Equity Value & Accessibility — Employees are eligible to participate in broad‑based equity programs, including an equity incentive plan and an ESPP. Feedback suggests this ownership opportunity can meaningfully augment total compensation in a growth‑focused setting.
-
Leave & Time Off Breadth — Company‑wide office shutdowns, standard PTO, and summer schedules are promoted to help people unplug. Feedback suggests these practices contribute to a well‑rounded time‑off offering.
Kymera Therapeutics Insights
What We Do
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years








